Asia- Pacific Clinical Trial Services Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
- DBMR706
- Pages: 100
- September 2018
- Total Views:1136
- Region : Global
- Data Bridge Market Research
- Market Research Report

Details
Asia Pacific clinical trial supplies market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market are demand in clinical trials worldwide, Increasing Incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in the future in market.
The key market players for Asia Pacific clinical trial services market are listed below:
Thermo Fisher Scientific Inc.,
Catalent, Inc.
Clinigen Group plc.
PAREXEL International Corporation
PCI Pharma Services
Almac Group
PAREXEL International Corporation
KLIFO
Bionical Ltd.
Alium Medical Limited
MYODERM
Clinigen Group plc.
Ancillare, LP
SIRO Clinpharm
CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.
The Asia Pacific clinical trial supplies market is segmented into:
Services
Clinical phases
Therapeutic uses
End User
On the basis of services Asia Pacific clinical trial supplies market is segmented into storage, manufacturing, packaging and labelling and distribution. In 2018, storage segment is expected to dominate the Asia Pacific clinical trial supplies market with the highest market share. On the basis of clinical phases the Asia Pacific clinical trial supplies market is segmented into phase III, phase II, phase IV and phase I
On the basis of therapeutic use the Asia Pacific clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others.
On the basis of end user the Asia Pacific clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.
Based on countries, the market is segmented into counties:
China
JAPAN
India
Australia
South Korea
Malaysia
Thailand
Singapore
Indonesia
Philippines
Rest of Asia-Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia Pacific Asia Pacific clinical trial supplies market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Table Of Content
Scope
Table Of Contents
1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Definition 18
1.3 Overview Of Asia-Pacific Clinical Trial Supplies Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 DBMR Market Challenge Matrix 30
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Demand Of Clinical Trials Worldwide 34
3.1.2 Increasing Incidences Of Diseases 35
3.1.3 Government Funds To R&D Investments 36
3.1.4 Development Of New Treatments Such As Personalized Medicine 36
3.2 Restraints 37
3.2.1 Adverse Effects Of Clinical Trials 37
3.2.2 Transportation Issue 37
3.3 Opportunities 38
3.3.1 New Drug Development And Availability In Emerging Countrires 38
3.4 Challenges 39
3.4.1 Longer Procedure Time Of Clinical Trials Approval 39
4 Executive Summary 40
5 Premium Insights 42
6 Asia-Pacific Clinical Trial Supplies Market, By Services 44
6.1 Overview 45
6.2 Storage 47
6.3 Manufacturing 49
6.4 Packaging And Labeling 50
6.5 Distribution 52
7 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases 53
7.1 Overview 54
7.2 Phase Iii 56
7.3 Phase Ii 57
7.4 Phase Iv 58
7.5 Phase I 59
8 Mjkasia-Pacific Clinical Trial Supplies Market, By Therapeutic Use 61
8.1 Overview 62
8.2 Oncology 64
8.3 Cardiovascular Disease 66
8.4 Dermatology 67
8.5 Metabolic Disorders 68
8.6 Infectious Disease 69
8.7 Respiratory Diseases 70
8.8 Cns And Mental Disorders 71
8.9 Blood Disorders 72
8.10 Others 73
9 Asia-Pacific Clinical Trial Supplies Market, By End User 74
9.1 Overview 75
9.2 Contract Research Organizations 77
9.3 Pharmaceutical And Biotechnology Companies 78
10 Asia-Pacific Clinical Trial Supplies Market, By Geography 80
10.1 Asia-Pacific 80
10.1.1 China 88
10.1.2 Japan 90
10.1.3 India 92
10.1.4 South Korea 94
10.1.5 Australia 96
10.1.6 Thailand 98
10.1.7 Malaysia 100
10.1.8 Singapore 102
10.1.9 Indonesia 104
10.1.10 Philippines 106
10.1.11 Rest Of Asia-Pacific 108
11 Asia-Pacific Clinical Trial Supplies Market, Company Landscape 109
11.1 Company Share Analysis: Asia-Pacific 109
12 Company Profile 110
12.1 Thermo Fisher Scientific Inc. 110
12.1.1 Company Overview 110
12.1.2 Revenue Analysis 110
12.1.3 Company Share Analysis 111
12.1.4 Product Portfolio 111
12.1.5 Recent Developments 112
12.2 Catalent, Inc.113
12.2.1 Company Overview 113
12.2.2 Revenue Analysis 113
12.2.3 Company Share Analysis 114
12.2.4 Product Portfolio 114
12.2.5 Recent Developments 115
12.3 Clinigen Group Plc. 116
12.3.1 Company Overview 116
12.3.2 Revenue Analysis 116
12.3.3 Revenue Analysis 117
12.3.4 Product Portfolio 117
12.3.5 Recent Developments 117
12.4 Parexel International Corporation 118
12.4.1 Company Overview 118
12.4.2 Revenue Analysis 118
12.4.3 Company Share Analysis 119
12.4.4 Product Portfolio 119
12.4.5 Recent Developments 119
12.5 Alium Medical Limited 120
12.5.1 Company Overview 120
12.5.2 Product Portfolio 120
12.5.3 Recent Developments 120
12.6 Almac Group 121
12.6.1 Company Overview 121
12.6.2 Geographic Presence 121
12.6.3 Product Portfolio 122
12.6.4 Recent Developments 122
12.7 Ancillare, Lp 123
12.7.1 Company Overview 123
12.7.2 Geographic Presence 123
12.7.3 Product Portfolio 124
12.7.4 Recent Developments 124
12.8 Biocair 125
12.8.1 Company Overview 125
12.8.2 Product Portfolio 125
12.8.3 Recent Developments 125
12.9 Bionical Ltd. 126
12.9.1 Company Overview 126
12.9.2 Gepographic Presence 126
12.9.3 Product Portfolio 127
12.9.4 Recent Developments 127
12.10 Clinical Supplies Management Holdings, Inc. 128
12.10.1 Company Overview 128
12.10.2 Geographic Presence 128
12.10.3 Product Portfolio 129
12.10.4 Recent Developments 129
12.11 Klifo 130
12.11.1 Company Overview 130
12.11.2 Geographic Presence 130
12.11.3 Product Portfolio 131
12.11.4 Recent Developments 131
12.12 Movianto 132
12.12.1 Company Overview 132
12.12.2 Geographic Presence 132
12.12.3 Product Portfolio 133
12.12.4 Recent Developments 133
12.13 Myoderm 134
12.13.1 Company Overview 134
12.13.2 Geographic Presence 134
12.13.3 Product Portfolio 135
12.13.4 Recent Developments 135
12.14 Pci Pharma Services 136
12.14.1 Company Overview 136
12.14.2 Geographic Presence 136
12.14.3 Product Portfolio 137
12.14.4 Recent Developments 137
12.15 Sharp 138
12.15.1 Company Overview 138
12.15.2 Geographic Presence 138
12.15.3 Product Portfolio 139
12.15.4 Recent Developments 140
12.16 Siro Clinpharm 141
12.16.1 Company Overview 141
12.16.2 Geographic Presence 141
12.16.3 Product Portfolio 142
12.16.4 Recent Developments 142
13 Related Reports 143
List Of Figure
List Of Figures
Figure 1 Asia-Pacific Clinical Trial Supplies Market: Segmentation 18
Figure 2 Asia-Pacific Clinical Trial Supplies Market: Data Triangulation 21
Figure 3 Asia-Pacific Clinical Trial Supplies Market: Droc Analysis 22
Figure 4 Asia-Pacific Clinical Trial Supplies Market:Bottom Up Approach 23
Figure 5 Asia-Pacific Clinical Trial Supplies Market:Top Down Approach 23
Figure 6 Asia-Pacific Clinical Trial Supplies Market: Interview Demographics 24
Figure 7 Asia-Pacific Clinical Trial Supplies Market: The Market Challenge Matrix 25
Figure 8 Drivers, Restraints, Opportunities And Challenges Of Asia-Pacific Clinical Trial Supplies Market 28
Figure 9 Asia-Pacific Clinical Trial Supplies Market: Segmentation 36
Figure 10 Rising Demand Clinical Trials Worldwide, Increasing Incidences Of Diseases To Drive The Market For Clinical Trial Supplies Market In The Forecast Period 2018 To 2025 37
Figure 11 Storage Segment Is Expected To Account For The Largest Share Of The Clinical Trial Supplies Market In 2018 & 2025 38
Figure 12 Asia-Pacific Clinical Trial Supplies Market: By Services, 2017 40
Figure 13 Asia-Pacific Clinical Trial Supplies Market: By Clinical Phases, 2017 49
Figure 14 Asia-Pacific Clinical Trial Supplies Market: By Therapeutic Use, 2017 57
Figure 15 Asia-Pacific Clinical Trial Supplies Market: By End User , 2017 70
Figure 16 Asia-Pacific Clinical Trial Supplies Market: Snapshot (2017) 76
Figure 17 Asia-Pacific Clinical Trial Supplies Market: By Country (2017) 77
Figure 18 Asia-Pacific Clinical Trial Supplies Market: By Country (2018 & 2025) 77
Figure 19 Asia-Pacific Clinical Trial Supplies Market, By Country (2017 & 2025) 78
Figure 20 Asia-Pacific Clinical Trial Supplies Market, By Services (2018 -2025) 78
Figure 21 Asia-Pacific Clinical Trial Supplies Market: Company Share 2017 (%) 104
List Of Table
List Of Tables
Table 1 Asia-Pacific Clinical Trial Supplies Market, By Services , USD Million (2016 -2025) 42
Table 2 Asia-Pacific Storage In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 44
Table 3 Asia-Pacific Manufacturing In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 45
Table 4 Asia-Pacific Packaging And Labeling In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 47
Table 5 Asia-Pacific Distribution In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 48
Table 6 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases, USD Million (2016 -2025) 51
Table 7 Asia-Pacific Phase Iii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 52
Table 8 Asia-Pacific Phase Ii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 53
Table 9 Asia-Pacific Phase Iv In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 54
Table 10 Asia-Pacific Phase I In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 56
Table 11 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, 2016-2025 (USD Million) 59
Table 12 Asia-Pacific Oncology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 61
Table 13 Asia-Pacific Cardivascular Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 62
Table 14 Asia-Pacific Dermatology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 63
Table 15 Asia-Pacific Metabolic Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 64
Table 16 Asia-Pacific Infectious Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 65
Table 17 Asia-Pacific Respiratory Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 66
Table 18 Asia-Pacific Cns And Mental Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 67
Table 19 Asia-Pacific Blood Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 68
Table 20 Asia-Pacific Others In Clinical Trial Supplies Market, By Region, 2016-2025 (USD Million) 69
Table 21 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 72
Table 22 Asia-Pacific Contract Research Organizations In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 73
Table 23 Asia-Pacific Pharmaceutical And Biotechnology Companies In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 74
Table 24 Asia-Pacific Clinical Trial Supplies Market , By Country, USD Million (2016-2025) 80
Table 25 Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 81
Table 26 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 82
Table 27 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 82
Table 28 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 83
Table 29 China Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 84
Table 30 China Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 84
Table 31 China Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 85
Table 32 China Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 85
Table 33 Japan Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 86
Table 34 Japan Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 86
Table 35 Japan Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 87
Table 36 Japan Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 87
Table 37 India Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 88
Table 38 India Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 88
Table 39 India Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 89
Table 40 India Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 89
Table 41 South Korea Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 90
Table 42 South Korea Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 90
Table 43 South Korea Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 91
Table 44 South Korea Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 91
Table 45 Australia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 92
Table 46 Australia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 92
Table 47 Australia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 93
Table 48 Australia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 93
Table 49 Thailand Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 94
Table 50 Thailand Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 94
Table 51 Thailand Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 95
Table 52 Thailand Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 95
Table 53 Malaysia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 96
Table 54 Malaysia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 96
Table 55 Malaysia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 97
Table 56 Malaysia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 97
Table 57 Singapore Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 98
Table 58 Singapore Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 98
Table 59 Singapore Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 99
Table 60 Singapore Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 99
Table 61 Indonesia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 100
Table 62 Indonesia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 100
Table 63 Indonesia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 101
Table 64 Indonesia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 101
Table 65 Philippines Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 102
Table 66 Philippines Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 102
Table 67 Philippines Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 103
Table 68 Philippines Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 103
Table 69 Rest Of Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 104
Licence Rights
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Thermo Fisher Scientific Inc.,
Catalent, Inc.
Clinigen Group plc.
PAREXEL International Corporation
PCI Pharma Services
Almac Group
PAREXEL International Corporation
KLIFO
Bionical Ltd.
Alium Medical Limited
MYODERM
Clinigen Group plc.
Ancillare, LP
SIRO Clinpharm
CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.
Company Profile
Company Profile Title
Asia Pacific clinical trial supplies market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market are demand in clinical trials worldwide, Increasing Incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in the future in market.
The key market players for Asia Pacific clinical trial services market are listed below:
Thermo Fisher Scientific Inc.,
Catalent, Inc.
Clinigen Group plc.
PAREXEL International Corporation
PCI Pharma Services
Almac Group
PAREXEL International Corporation
KLIFO
Bionical Ltd.
Alium Medical Limited
MYODERM
Clinigen Group plc.
Ancillare, LP
SIRO Clinpharm
CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.
The Asia Pacific clinical trial supplies market is segmented into:
Services
Clinical phases
Therapeutic uses
End User
On the basis of services Asia Pacific clinical trial supplies market is segmented into storage, manufacturing, packaging and labelling and distribution. In 2018, storage segment is expected to dominate the Asia Pacific clinical trial supplies market with the highest market share. On the basis of clinical phases the Asia Pacific clinical trial supplies market is segmented into phase III, phase II, phase IV and phase I
On the basis of therapeutic use the Asia Pacific clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others.
On the basis of end user the Asia Pacific clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.
Based on countries, the market is segmented into counties:
China
JAPAN
India
Australia
South Korea
Malaysia
Thailand
Singapore
Indonesia
Philippines
Rest of Asia-Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia Pacific Asia Pacific clinical trial supplies market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Scope
Table Of Contents
1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Definition 18
1.3 Overview Of Asia-Pacific Clinical Trial Supplies Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 DBMR Market Challenge Matrix 30
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Demand Of Clinical Trials Worldwide 34
3.1.2 Increasing Incidences Of Diseases 35
3.1.3 Government Funds To R&D Investments 36
3.1.4 Development Of New Treatments Such As Personalized Medicine 36
3.2 Restraints 37
3.2.1 Adverse Effects Of Clinical Trials 37
3.2.2 Transportation Issue 37
3.3 Opportunities 38
3.3.1 New Drug Development And Availability In Emerging Countrires 38
3.4 Challenges 39
3.4.1 Longer Procedure Time Of Clinical Trials Approval 39
4 Executive Summary 40
5 Premium Insights 42
6 Asia-Pacific Clinical Trial Supplies Market, By Services 44
6.1 Overview 45
6.2 Storage 47
6.3 Manufacturing 49
6.4 Packaging And Labeling 50
6.5 Distribution 52
7 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases 53
7.1 Overview 54
7.2 Phase Iii 56
7.3 Phase Ii 57
7.4 Phase Iv 58
7.5 Phase I 59
8 Mjkasia-Pacific Clinical Trial Supplies Market, By Therapeutic Use 61
8.1 Overview 62
8.2 Oncology 64
8.3 Cardiovascular Disease 66
8.4 Dermatology 67
8.5 Metabolic Disorders 68
8.6 Infectious Disease 69
8.7 Respiratory Diseases 70
8.8 Cns And Mental Disorders 71
8.9 Blood Disorders 72
8.10 Others 73
9 Asia-Pacific Clinical Trial Supplies Market, By End User 74
9.1 Overview 75
9.2 Contract Research Organizations 77
9.3 Pharmaceutical And Biotechnology Companies 78
10 Asia-Pacific Clinical Trial Supplies Market, By Geography 80
10.1 Asia-Pacific 80
10.1.1 China 88
10.1.2 Japan 90
10.1.3 India 92
10.1.4 South Korea 94
10.1.5 Australia 96
10.1.6 Thailand 98
10.1.7 Malaysia 100
10.1.8 Singapore 102
10.1.9 Indonesia 104
10.1.10 Philippines 106
10.1.11 Rest Of Asia-Pacific 108
11 Asia-Pacific Clinical Trial Supplies Market, Company Landscape 109
11.1 Company Share Analysis: Asia-Pacific 109
12 Company Profile 110
12.1 Thermo Fisher Scientific Inc. 110
12.1.1 Company Overview 110
12.1.2 Revenue Analysis 110
12.1.3 Company Share Analysis 111
12.1.4 Product Portfolio 111
12.1.5 Recent Developments 112
12.2 Catalent, Inc.113
12.2.1 Company Overview 113
12.2.2 Revenue Analysis 113
12.2.3 Company Share Analysis 114
12.2.4 Product Portfolio 114
12.2.5 Recent Developments 115
12.3 Clinigen Group Plc. 116
12.3.1 Company Overview 116
12.3.2 Revenue Analysis 116
12.3.3 Revenue Analysis 117
12.3.4 Product Portfolio 117
12.3.5 Recent Developments 117
12.4 Parexel International Corporation 118
12.4.1 Company Overview 118
12.4.2 Revenue Analysis 118
12.4.3 Company Share Analysis 119
12.4.4 Product Portfolio 119
12.4.5 Recent Developments 119
12.5 Alium Medical Limited 120
12.5.1 Company Overview 120
12.5.2 Product Portfolio 120
12.5.3 Recent Developments 120
12.6 Almac Group 121
12.6.1 Company Overview 121
12.6.2 Geographic Presence 121
12.6.3 Product Portfolio 122
12.6.4 Recent Developments 122
12.7 Ancillare, Lp 123
12.7.1 Company Overview 123
12.7.2 Geographic Presence 123
12.7.3 Product Portfolio 124
12.7.4 Recent Developments 124
12.8 Biocair 125
12.8.1 Company Overview 125
12.8.2 Product Portfolio 125
12.8.3 Recent Developments 125
12.9 Bionical Ltd. 126
12.9.1 Company Overview 126
12.9.2 Gepographic Presence 126
12.9.3 Product Portfolio 127
12.9.4 Recent Developments 127
12.10 Clinical Supplies Management Holdings, Inc. 128
12.10.1 Company Overview 128
12.10.2 Geographic Presence 128
12.10.3 Product Portfolio 129
12.10.4 Recent Developments 129
12.11 Klifo 130
12.11.1 Company Overview 130
12.11.2 Geographic Presence 130
12.11.3 Product Portfolio 131
12.11.4 Recent Developments 131
12.12 Movianto 132
12.12.1 Company Overview 132
12.12.2 Geographic Presence 132
12.12.3 Product Portfolio 133
12.12.4 Recent Developments 133
12.13 Myoderm 134
12.13.1 Company Overview 134
12.13.2 Geographic Presence 134
12.13.3 Product Portfolio 135
12.13.4 Recent Developments 135
12.14 Pci Pharma Services 136
12.14.1 Company Overview 136
12.14.2 Geographic Presence 136
12.14.3 Product Portfolio 137
12.14.4 Recent Developments 137
12.15 Sharp 138
12.15.1 Company Overview 138
12.15.2 Geographic Presence 138
12.15.3 Product Portfolio 139
12.15.4 Recent Developments 140
12.16 Siro Clinpharm 141
12.16.1 Company Overview 141
12.16.2 Geographic Presence 141
12.16.3 Product Portfolio 142
12.16.4 Recent Developments 142
13 Related Reports 143
List Of Figure
List Of Figures
Figure 1 Asia-Pacific Clinical Trial Supplies Market: Segmentation 18
Figure 2 Asia-Pacific Clinical Trial Supplies Market: Data Triangulation 21
Figure 3 Asia-Pacific Clinical Trial Supplies Market: Droc Analysis 22
Figure 4 Asia-Pacific Clinical Trial Supplies Market:Bottom Up Approach 23
Figure 5 Asia-Pacific Clinical Trial Supplies Market:Top Down Approach 23
Figure 6 Asia-Pacific Clinical Trial Supplies Market: Interview Demographics 24
Figure 7 Asia-Pacific Clinical Trial Supplies Market: The Market Challenge Matrix 25
Figure 8 Drivers, Restraints, Opportunities And Challenges Of Asia-Pacific Clinical Trial Supplies Market 28
Figure 9 Asia-Pacific Clinical Trial Supplies Market: Segmentation 36
Figure 10 Rising Demand Clinical Trials Worldwide, Increasing Incidences Of Diseases To Drive The Market For Clinical Trial Supplies Market In The Forecast Period 2018 To 2025 37
Figure 11 Storage Segment Is Expected To Account For The Largest Share Of The Clinical Trial Supplies Market In 2018 & 2025 38
Figure 12 Asia-Pacific Clinical Trial Supplies Market: By Services, 2017 40
Figure 13 Asia-Pacific Clinical Trial Supplies Market: By Clinical Phases, 2017 49
Figure 14 Asia-Pacific Clinical Trial Supplies Market: By Therapeutic Use, 2017 57
Figure 15 Asia-Pacific Clinical Trial Supplies Market: By End User , 2017 70
Figure 16 Asia-Pacific Clinical Trial Supplies Market: Snapshot (2017) 76
Figure 17 Asia-Pacific Clinical Trial Supplies Market: By Country (2017) 77
Figure 18 Asia-Pacific Clinical Trial Supplies Market: By Country (2018 & 2025) 77
Figure 19 Asia-Pacific Clinical Trial Supplies Market, By Country (2017 & 2025) 78
Figure 20 Asia-Pacific Clinical Trial Supplies Market, By Services (2018 -2025) 78
Figure 21 Asia-Pacific Clinical Trial Supplies Market: Company Share 2017 (%) 104
List Of Table
List Of Tables
Table 1 Asia-Pacific Clinical Trial Supplies Market, By Services , USD Million (2016 -2025) 42
Table 2 Asia-Pacific Storage In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 44
Table 3 Asia-Pacific Manufacturing In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 45
Table 4 Asia-Pacific Packaging And Labeling In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 47
Table 5 Asia-Pacific Distribution In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 48
Table 6 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases, USD Million (2016 -2025) 51
Table 7 Asia-Pacific Phase Iii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 52
Table 8 Asia-Pacific Phase Ii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 53
Table 9 Asia-Pacific Phase Iv In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 54
Table 10 Asia-Pacific Phase I In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 56
Table 11 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, 2016-2025 (USD Million) 59
Table 12 Asia-Pacific Oncology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 61
Table 13 Asia-Pacific Cardivascular Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 62
Table 14 Asia-Pacific Dermatology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 63
Table 15 Asia-Pacific Metabolic Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 64
Table 16 Asia-Pacific Infectious Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 65
Table 17 Asia-Pacific Respiratory Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 66
Table 18 Asia-Pacific Cns And Mental Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 67
Table 19 Asia-Pacific Blood Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 68
Table 20 Asia-Pacific Others In Clinical Trial Supplies Market, By Region, 2016-2025 (USD Million) 69
Table 21 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 72
Table 22 Asia-Pacific Contract Research Organizations In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 73
Table 23 Asia-Pacific Pharmaceutical And Biotechnology Companies In Clinical Trial Supplies Market, By Region, USD Million (2016-2025) 74
Table 24 Asia-Pacific Clinical Trial Supplies Market , By Country, USD Million (2016-2025) 80
Table 25 Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 81
Table 26 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 82
Table 27 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 82
Table 28 Asia-Pacific Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 83
Table 29 China Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 84
Table 30 China Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 84
Table 31 China Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 85
Table 32 China Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 85
Table 33 Japan Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 86
Table 34 Japan Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 86
Table 35 Japan Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 87
Table 36 Japan Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 87
Table 37 India Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 88
Table 38 India Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 88
Table 39 India Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 89
Table 40 India Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 89
Table 41 South Korea Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 90
Table 42 South Korea Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 90
Table 43 South Korea Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 91
Table 44 South Korea Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 91
Table 45 Australia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 92
Table 46 Australia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 92
Table 47 Australia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 93
Table 48 Australia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 93
Table 49 Thailand Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 94
Table 50 Thailand Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 94
Table 51 Thailand Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 95
Table 52 Thailand Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 95
Table 53 Malaysia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 96
Table 54 Malaysia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 96
Table 55 Malaysia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 97
Table 56 Malaysia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 97
Table 57 Singapore Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 98
Table 58 Singapore Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 98
Table 59 Singapore Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 99
Table 60 Singapore Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 99
Table 61 Indonesia Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 100
Table 62 Indonesia Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 100
Table 63 Indonesia Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 101
Table 64 Indonesia Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 101
Table 65 Philippines Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 102
Table 66 Philippines Clinical Trial Supplies Market, By Clinical Phase, USD Million (2016-2025) 102
Table 67 Philippines Clinical Trial Supplies Market, By Therapeutic Uses, USD Million (2016-2025) 103
Table 68 Philippines Clinical Trial Supplies Market, By End User, USD Million (2016-2025) 103
Table 69 Rest Of Asia-Pacific Clinical Trial Supplies Market, By Services, USD Million (2016-2025) 104
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Thermo Fisher Scientific Inc.,
Catalent, Inc.
Clinigen Group plc.
PAREXEL International Corporation
PCI Pharma Services
Almac Group
PAREXEL International Corporation
KLIFO
Bionical Ltd.
Alium Medical Limited
MYODERM
Clinigen Group plc.
Ancillare, LP
SIRO Clinpharm
CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.